European Focused Dividend Fund
$150,000,000.00
15,000,000.00 Units at $10.00
Initial Public Offering - Closed - Friday, November 24, 2017
Company Description
European Focused Dividend Fund is a non-redeemable investment fund company. Its investment objective is to enhanced long-term return through capital appreciation of the Fund's investment portfolio. The manager of the fund will be Middlefield Limited and Middlefield Capital Corporation will provide the fund with investment management advice.
| Address: |
812 Memorial Drive N.W. Calgary, Alberta, T2N 3C8 Canada |
|---|---|
| Phone Number: | 403 269 2100 |
| Fax Number: | 403 269 2911 |
| Website: |
| Industry: | Financial & Investment Services |
|---|---|
| Closing Date: | Friday, November 24, 2017 |
| 1st Day of Trading: | Friday, November 24, 2017 |
| Primary Symbol: | EF.UN |
| Exchange: | Toronto |
Proceeds
The net proceeds of the offering will be used to invest primarily in securities of European dividend issuers and to fund the ongoing fees and expenses of the Fund.
| Gross Proceeds: | $150,000,000.00 |
|---|---|
| Underwrting Fees: | $6,750,000.00 |
| Expense Offering: | $500,000.00 |
| Net Proceeds: | $142,750,000.00 |
| Lead Underwriter: | CIBC World Markets Inc. |
|---|---|
| Other Underwriter(s): |
RBC Dominion Securities Inc. BMO Nesbitt Burns Inc. TD Securities Inc. Scotia Capital Inc. National Bank Financial Inc. Desjardins Securities Inc. GMP Securities Ltd. Raymond James Ltd. Middlefield Capital Corporation Canaccord Genuity Corp. Manulife Securities Incorporated Mackie Research Capital Corporation Echelon Wealth Partners Inc. |
Performance
| 1 day | 1 week | 1 month | 6 months | Inception | |
|---|---|---|---|---|---|
| Recent Performance | 0.00 % | -0.87 % | -3.53 % | -16.30 % | -31.70 % |
| Post IPO Performance | -0.50 % | -0.50 % | -7.50 % |
The content of this page is transmitted strictly for informational purposes. Investments must be selected in accordance with the investor's respective objectives. Desjardins Online Brokerage does not issue any recommendations or endorsements concerning any particular product, its potential value or appropriateness, or any specific strategy. It is highly recommended to read the prospectus before making any type of investment.